Leprosy Mailing List – October 12, 2024
Ref.: (LML) Post-Exposure Prophylaxis and Vaccins
From: Ben Naafs, Munnekeburen, the Netherlands
Dear Pieter,
The TropMed Society of Brazil asked me to give a Zoom presentation about: "Whether Technological advances improved our understanding of immune responses contributed to the development of vaccines and the treatment of leprosy reaction" Later they added Prep to it.
I adapted this presentation for the readers of LML and hope they will comment on it. Negative appreciations are certainly welcome too, when the writer is willing to share on LML under his own name.
The first part "Leprosy, reaction diagnosis and treatment" was sent last week. Today we will send both Prep and vaccination.
It is worth mentioning that the first trials of chemoprophylaxis were done in South America (Arq Min Leprol. 1959 jul;19:384-9).
With regards,
Ben
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << edit...@gmail.com
--You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/668edff1-a4a0-4f06-b01d-9d5eae563001n%40googlegroups.com.
No comments:
Post a Comment